SEC Form 4 reporting owner

Davis Todd C

Davis Todd C has filed 13 Form 4 transactions reported between February 14, 2026 and June 30, 2026, as Chief Executive Officer of LIGAND PHARMACEUTICALS INC, Director of Pelthos Therapeutics Inc. and Director of PALVELLA THERAPEUTICS, INC..

Name as filed: Davis Todd C

Open-market buys, 24 mo

$1000K

2 lines

Open-market sales, 24 mo

None

reported

Companies

with Form 4 filings

Latest transaction

Jun 30, 2026

transaction date

Roles and reported holdings

LGNDLIGAND PHARMACEUTICALS INC
Feb 14, 2026 – Jun 30, 2026
Chief Executive Officer
Held directly188,886 sh as of Feb 15, 2026 · Form 4
PTHSPelthos Therapeutics Inc.
Jun 11, 2026
Director
Held directly75,834 sh as of Jun 11, 2026 · Form 4
24 months: $1000K bought
PVLAPALVELLA THERAPEUTICS, INC.
Jun 10, 2026
Director
No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 13 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Jun 30, 2026	LGNDChief Executive Officer	Other acquisition or dispositionCode J · direct	132	$160.71	$21K@ $160.71	199,513	Form 4
Jun 11, 2026	PTHSDirector	Open-market purchaseCode P · direct	503	$28.73	$14K@ $28.73	75,834	Form 4
Jun 11, 2026	PTHSDirector	Open-market purchaseCode P · direct	35,445	$27.80	$986K@ $27.80	75,331	Form 4
Jun 10, 2026	PVLADirector	Grant or awardCode A · direct	3,000	—	—	3,000	Form 4
Mar 2, 2026	LGNDChief Executive Officer	Grant or awardCode A · direct	50,058	—	—	50,058	Form 4
Mar 2, 2026	LGNDChief Executive Officer	Grant or awardCode A · direct	10,495	—	—	199,381	Form 4
Feb 15, 2026	LGNDChief Executive Officer	Shares withheld for tax or exercise priceCode F · direct	2,805	$183.83	$516K@ $183.83	188,886	Form 4
Feb 15, 2026	LGNDChief Executive Officer	Shares withheld for tax or exercise priceCode F · direct	4,255	$183.83	$782K@ $183.83	191,691	Form 4
Feb 15, 2026	LGNDChief Executive Officer	Shares withheld for tax or exercise priceCode F · direct	2,039	$183.83	$375K@ $183.83	195,946	Form 4
Feb 14, 2026	LGNDChief Executive Officer	Shares withheld for tax or exercise priceCode F · direct	15,600	$183.83	$2.9M@ $183.83	197,985	Form 4
Feb 14, 2026	LGNDChief Executive Officer	Grant or awardCode A · direct	39,644	—	—	213,585	Form 4
Feb 14, 2026	LGNDChief Executive Officer	Shares withheld for tax or exercise priceCode F · direct	8,178	$183.83	$1.5M@ $183.83	173,941	Form 4
Feb 14, 2026	LGNDChief Executive Officer	Grant or awardCode A · direct	20,782	—	—	182,119	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.